Context: For many patients, adhering to postmenopausal osteoporosis treatment is a challenge. Higher treatment satisfaction is associated with greater persistence with these therapies, which is associated with better outcomes.
Objective: To evaluate the change in treatment satisfaction in postmenopausal women who were suboptimally adherent to daily or
Conclusions: Women with low adherence to oral bisphosphonates reported greater treatment satisfaction when transitioned to denosumab versus switching to a monthly oral bisphosphonate.
READ FULL ARTICLE From press.endocrine.org